超声内镜引导下胃造口术治疗良性胃出口梗阻的长期临床成功。

IF 4.7
Antonio Martinez-Ortega, F Javier García-Alonso, Natalia Marcos Carrasco, Amaia Arrubla Gamboa, Lucía Guilabert, Carlos Abril García, Félix Téllez-Avila, José Carlos Subtil Íñigo, Belén Martínez-Moreno, Marina Cobreros Del Caz, Juan J Vila, Vicente Sanchiz Soler, José R Aparicio Tormo, Alejandro Repiso Ortega, José Miguel Esteban, Antonio Velasco-Guardado, Ferrán Gónzalez-Huix, Carlos de la Serna Higuera, Manuel Perez-Miranda
{"title":"超声内镜引导下胃造口术治疗良性胃出口梗阻的长期临床成功。","authors":"Antonio Martinez-Ortega, F Javier García-Alonso, Natalia Marcos Carrasco, Amaia Arrubla Gamboa, Lucía Guilabert, Carlos Abril García, Félix Téllez-Avila, José Carlos Subtil Íñigo, Belén Martínez-Moreno, Marina Cobreros Del Caz, Juan J Vila, Vicente Sanchiz Soler, José R Aparicio Tormo, Alejandro Repiso Ortega, José Miguel Esteban, Antonio Velasco-Guardado, Ferrán Gónzalez-Huix, Carlos de la Serna Higuera, Manuel Perez-Miranda","doi":"10.1111/den.15087","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) is an established treatment for malignant gastric outlet obstruction (GOO). Data on EUS-GE for benign GOO (bGOO) are limited. This study aimed to evaluate long-term clinical outcomes of EUS-GE in bGOO.</p><p><strong>Methods: </strong>Retrospective study on consecutive patients who underwent EUS-GE for bGOO using lumen apposing metal stents (LAMS) at 9 Spanish centers. The primary outcome was the ability to regain and maintain oral feeding. Secondary outcomes included technical success, immediate clinical success, LAMS dysfunction, and adverse event rates.</p><p><strong>Results: </strong>Sixty-two patients (75.8% male) with a median age of 65 years (56.9-74) were included. Most cases of bGOO were related to chronic (35.5%) or acute (24.2%) pancreatitis. Technical success was achieved in 61 (98.4%), and immediate clinical success in 57 (91.9%) patients. Among patients reaching immediate clinical success, the median LAMS indwell time was 505 (201-848) days. LAMS dysfunction developed in 7 (12.3%) patients after a median of 1200 (IQR: 94-1568) days. Oral feeding at 24 months was maintained in 85.3% patients overall and in 93.6% patients among those with immediate clinical success. Seven adverse events, including a fatal aspiration pneumonia and a fatal delayed bleeding, occurred in 6 (9.7%) patients.</p><p><strong>Conclusions: </strong>EUS-GE has a high immediate clinical success rate in patients with bGOO and a low risk of stent dysfunction.</p><p><strong>Trial registration: </strong>Promotor center identification number: PI-24-448-H.</p>","PeriodicalId":72813,"journal":{"name":"Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-Term Clinical Success of Endoscopic Ultrasound-Guided Gastroenterostomy in Benign Gastric Outlet Obstruction.\",\"authors\":\"Antonio Martinez-Ortega, F Javier García-Alonso, Natalia Marcos Carrasco, Amaia Arrubla Gamboa, Lucía Guilabert, Carlos Abril García, Félix Téllez-Avila, José Carlos Subtil Íñigo, Belén Martínez-Moreno, Marina Cobreros Del Caz, Juan J Vila, Vicente Sanchiz Soler, José R Aparicio Tormo, Alejandro Repiso Ortega, José Miguel Esteban, Antonio Velasco-Guardado, Ferrán Gónzalez-Huix, Carlos de la Serna Higuera, Manuel Perez-Miranda\",\"doi\":\"10.1111/den.15087\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and aims: </strong>Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) is an established treatment for malignant gastric outlet obstruction (GOO). Data on EUS-GE for benign GOO (bGOO) are limited. This study aimed to evaluate long-term clinical outcomes of EUS-GE in bGOO.</p><p><strong>Methods: </strong>Retrospective study on consecutive patients who underwent EUS-GE for bGOO using lumen apposing metal stents (LAMS) at 9 Spanish centers. The primary outcome was the ability to regain and maintain oral feeding. Secondary outcomes included technical success, immediate clinical success, LAMS dysfunction, and adverse event rates.</p><p><strong>Results: </strong>Sixty-two patients (75.8% male) with a median age of 65 years (56.9-74) were included. Most cases of bGOO were related to chronic (35.5%) or acute (24.2%) pancreatitis. Technical success was achieved in 61 (98.4%), and immediate clinical success in 57 (91.9%) patients. Among patients reaching immediate clinical success, the median LAMS indwell time was 505 (201-848) days. LAMS dysfunction developed in 7 (12.3%) patients after a median of 1200 (IQR: 94-1568) days. Oral feeding at 24 months was maintained in 85.3% patients overall and in 93.6% patients among those with immediate clinical success. Seven adverse events, including a fatal aspiration pneumonia and a fatal delayed bleeding, occurred in 6 (9.7%) patients.</p><p><strong>Conclusions: </strong>EUS-GE has a high immediate clinical success rate in patients with bGOO and a low risk of stent dysfunction.</p><p><strong>Trial registration: </strong>Promotor center identification number: PI-24-448-H.</p>\",\"PeriodicalId\":72813,\"journal\":{\"name\":\"Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/den.15087\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/den.15087","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景与目的:超声内镜引导下的胃肠造口术(EUS-GE)是治疗恶性胃出口梗阻(GOO)的常用方法。EUS-GE诊断良性粘胶瘤(bGOO)的数据有限。本研究旨在评估EUS-GE治疗bGOO的长期临床结果。方法:回顾性研究西班牙9个中心连续使用腔内金属支架(LAMS)行EUS-GE治疗bGOO的患者。主要结果是恢复和维持口服喂养的能力。次要结局包括技术成功、即时临床成功、LAMS功能障碍和不良事件发生率。结果:纳入62例患者,男性75.8%,中位年龄65岁(56.9-74岁)。大多数bGOO病例与慢性(35.5%)或急性(24.2%)胰腺炎有关。技术成功61例(98.4%),即刻临床成功57例(91.9%)。在立即获得临床成功的患者中,LAMS留置时间中位数为505(201-848)天。7例(12.3%)患者在中位1200 (IQR: 94-1568)天后出现LAMS功能障碍。总体而言,85.3%的患者在24个月时维持口服喂养,在立即取得临床成功的患者中,这一比例为93.6%。6例(9.7%)患者发生了7个不良事件,包括致命性吸入性肺炎和致命性延迟性出血。结论:EUS-GE治疗bGOO患者临床即刻成功率高,支架功能障碍风险低。试验注册:启动子中心识别号:PI-24-448-H。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Long-Term Clinical Success of Endoscopic Ultrasound-Guided Gastroenterostomy in Benign Gastric Outlet Obstruction.

Background and aims: Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) is an established treatment for malignant gastric outlet obstruction (GOO). Data on EUS-GE for benign GOO (bGOO) are limited. This study aimed to evaluate long-term clinical outcomes of EUS-GE in bGOO.

Methods: Retrospective study on consecutive patients who underwent EUS-GE for bGOO using lumen apposing metal stents (LAMS) at 9 Spanish centers. The primary outcome was the ability to regain and maintain oral feeding. Secondary outcomes included technical success, immediate clinical success, LAMS dysfunction, and adverse event rates.

Results: Sixty-two patients (75.8% male) with a median age of 65 years (56.9-74) were included. Most cases of bGOO were related to chronic (35.5%) or acute (24.2%) pancreatitis. Technical success was achieved in 61 (98.4%), and immediate clinical success in 57 (91.9%) patients. Among patients reaching immediate clinical success, the median LAMS indwell time was 505 (201-848) days. LAMS dysfunction developed in 7 (12.3%) patients after a median of 1200 (IQR: 94-1568) days. Oral feeding at 24 months was maintained in 85.3% patients overall and in 93.6% patients among those with immediate clinical success. Seven adverse events, including a fatal aspiration pneumonia and a fatal delayed bleeding, occurred in 6 (9.7%) patients.

Conclusions: EUS-GE has a high immediate clinical success rate in patients with bGOO and a low risk of stent dysfunction.

Trial registration: Promotor center identification number: PI-24-448-H.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信